Project Grant R35GM161161
- Federal Grant Award Summary The University of Pennsylvania received a $406,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025, through April 30, 2030. This award supports fundamental research investigating two interconnected research directions: (1) transcription factor (TF) functional divergence and how members of TF families coordinate complex developmental...
- Federal Project Grant Award Summary The University of Pennsylvania received a $446,875 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 8, 2025, with a completion date of June 30, 2030. This award supports fundamental biomedical research aimed at deciphering novel cell death mechanisms and metabolic reprogramming in response to microenvironmental stress. The research...
- Federal Project Grant Award Summary The University of Pennsylvania received a $148,050 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2025 through May 31, 2027. This research project investigates the mechanistic roles of protein arginine methyltransferase 1 (PRMT1) and the RNA-binding protein heterogeneous nuclear ribonucleoprotein K (HNRNPK) in regulating the spatial...
- Federal Project Grant Award Summary The University of Pennsylvania received a $487,287 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 10, 2026, with a completion date of January 31, 2031. The award supports fundamental research investigating novel mechanisms of circadian rhythm control that operate independently of traditional genetic feedback loops. The research...
- Federal Project Grant Award Summary The University of Pennsylvania received a $443,806 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. This award supports fundamental research investigating the coordination of chemical modifications across multiple RNA (ribonucleic acid) species, specifically examining how enzyme-mediated modifications...
- Federal Grant Award Summary The University of Pennsylvania received a $900,000 collaborative research project grant from the National Science Foundation's Division of Molecular and Cellular Biosciences (CFDA 47.074 - Biological Sciences program) on September 15, 2025, with completion targeted for August 31, 2028. This award funds fundamental research to elucidate the mechanistic drivers of transcription factor (TF) functional divergence—a key evolutionary mechanism underlying cellular and...
- Federal Project Grant Award Summary The University of Pennsylvania received a $406,250 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026, with completion targeted for December 31, 2030. The award funds the development of correlated factor models and statistical methodologies for analyzing complex multimodal biological datasets. The project will deliver three...
- Federal Project Grant Award Summary The University of Pennsylvania received a $556,510 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 1, 2025, with completion targeted for March 31, 2030. This award funds fundamental research investigating the molecular mechanisms and evolutionary basis of the rhoptry secretion system in unicellular eukaryotes within the Alveolata superphylum,...
- Federal Project Grant Award Summary The University of Pennsylvania received a $460,771 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026, through December 31, 2030. This award funds fundamental research investigating the molecular mechanisms that regulate zygotic genome activation (ZGA)—the critical developmental transition from maternal to zygotic control during early...
- Federal Project Grant Award Summary The University of Pennsylvania received a $406,250 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) on June 12, 2025, with a completion date of April 30, 2030. This five-year research initiative investigates how circadian and metabolic rhythms regulate cell maturation and maintain mature cellular phenotypes. The research employs in situ multimodal...
The University of Pennsylvania received a $924,095 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2031. This five-year award supports fundamental research investigating the molecular mechanisms controlling actin cytoskeleton dynamics, a critical area of basic biomedical science that underpins understanding of cellular structure and function. The funded research addresses four major scientific objectives: (1) elucidating how the Arp2/3 (actin-related protein 2/3) complex is activated through nucleation-promoting factors and the roles of regulatory proteins like coronin-7 in modulating filament branching; (2) characterizing how filament-capping proteins, AIP1 (actin-interacting protein 1), and cofilin cooperatively regulate actin filament disassembly at barbed and pointed ends; (3) determining the structural and functional mechanisms by which Miro recruits molecular motors and effectors to mitochondria to regulate mitochondrial dynamics; and (4) developing next-generation photoswitches that enable optogenetic control of actin cytoskeletal components with enhanced specificity and efficacy. These research deliverables will advance fundamental knowledge of cytoskeletal protein mechanisms applicable to multiple disease areas and cellular processes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $924.1k | 2/26/26 |